Innovatis

Innovatis was a leading provider of automated cell analysis systems designed for the biopharmaceutical and life science industries. The company specialized in developing high-precision instruments for cell counting, viability testing, and metabolite analysis, which are critical for monitoring cell culture processes. Its flagship product line, the Cedex series, became an industry standard by automating the traditional manual Trypan Blue exclusion method. In 2009, Innovatis was acquired by Roche Applied Science to bolster its portfolio in bioprocess monitoring and cell analysis. Today, the technology originally developed by Innovatis remains a core component of Roche's bioprocessing solutions.